Cytoplasmic viscosity is a potential biomarker for metastatic breast cancer cells

被引:5
|
作者
Dessard, Marie [1 ,2 ]
Manneville, Jean-Baptiste [1 ]
Berret, Jean-Francois [1 ]
机构
[1] Univ Paris Cite, CNRS, Matiere & Syst Complexes, F-75013 Paris, France
[2] Aix Marseille Univ, INSERM, CIML, CNRS, F-13009 Marseille, France
来源
NANOSCALE ADVANCES | 2024年 / 6卷 / 06期
关键词
INTRACELLULAR MECHANICS; LIVING CELLS; RHEOLOGY; VISCOELASTICITY; TRANSFORMATION; DEFORMABILITY; ORGANIZATION; CARCINOMA; CORRELATE; DYNAMICS;
D O I
10.1039/d4na00003j
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Cellular microrheology has shown that cancer cells with high metastatic potential are softer compared to non-tumorigenic normal cells. These findings rely on measuring the apparent Young's modulus of whole cells using primarily atomic force microscopy. The present study aims to explore whether alternative mechanical parameters have discriminating features with regard to metastatic potential. Magnetic rotational spectroscopy (MRS) is employed in the examination of mammary epithelial cell lines: MCF-7 and MDA-MB-231, representing low and high metastatic potential, along with normal-like MCF-10A cells. MRS utilizes active micron-sized magnetic wires in a rotating magnetic field to measure the viscosity and elastic modulus of the cytoplasm. All three cell lines display viscoelastic behavior, with cytoplasmic viscosities ranging from 10 to 70 Pa s and elastic moduli from 30 to 80 Pa. It is found that the tumorigenic MCF-7 and MDA-MB-231 cells are softer than the MCF-10A cells, with a twofold decrease in the elastic modulus. To differentiate cells with low and high malignancy however, viscosity emerges as the more discriminating parameter, as MCF-7 exhibits a 5 times higher viscosity as compared to MDA-MB-231. These findings highlight the sensitivity of cytoplasmic viscosity to metastatic activity, suggesting its potential use as a mechanical marker for malignant cancer cells. Intracellular microrheology reveals static viscosity, not elastic modulus, as a potential marker for invasive and metastatic cancer cells.
引用
收藏
页码:1727 / 1738
页数:12
相关论文
共 50 条
  • [31] BORIS: A potential novel breast cancer biomarker
    Apte, A.
    Chandrasekharan, S.
    Klenova, E.
    CANCER RESEARCH, 2013, 73
  • [32] Can Biomarker Assessment on Circulating Tumor Cells Help Direct Therapy in Metastatic Breast Cancer?
    Turner, Natalie
    Pestrin, Marta
    Galardi, Francesca
    De Luca, Francesca
    Malorni, Luca
    Di Leo, Angelo
    CANCERS, 2014, 6 (02) : 684 - 707
  • [33] Modulation of connexin expression profile alters metastatic potential of breast cancer cells
    Li, Zhongyong
    Zhou, Zhiyi
    Welch, Danny R.
    Donahue, Henry J.
    CANCER RESEARCH, 2006, 66 (08)
  • [34] Circulating tumor cells in metastatic breast cancer: clinical relevance and biological potential
    Arkadius, Polasik
    Marie, Tzschaschel
    Fabienne, Schochter
    Thomas, W. P. Friedl
    Brigitte, Rack
    Andreas, Hartkopf
    Peter, A. Fasching
    Andreas, Schneeweiss
    Volkmar, Mueller
    Jens, Huober
    Wolfgang, Janni
    Tanja, Fehm
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2019, 31 (01) : 76 - 81
  • [35] Reduced Plakoglobin Expression Increases the Metastatic Potential of Breast Cancer Cells.
    Ottewell, P. D.
    Whitworth, J.
    Cross, S. S.
    Nutter, F. H.
    Holen, I.
    CANCER RESEARCH, 2011, 71
  • [36] Expression of Cx43 in breast cancer cells decreases their metastatic potential
    Li, Z.
    Zhou, Z.
    Welch, D. R.
    Donahue, H. J.
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 : 57 - 58
  • [37] Role of metastatic potential in the adhesion of human breast cancer cells to endothelial monolayers
    Moss, MA
    Zimmer, S
    Anderson, KW
    ANTICANCER RESEARCH, 2000, 20 (3A) : 1425 - 1433
  • [38] RhoC is a determinant of metastatic potential and affects the abundance of breast cancer stem cells
    Zhu, Lian
    Rosenthal, Devin T.
    Zhang, Jie
    Bao, Liwei
    Wu, Zhifen
    Toy, Kathy
    Kleer, Celina G.
    Merajver, Sofia D.
    CANCER RESEARCH, 2012, 72
  • [39] Proteomic Profiling of Exosomes Secreted by Breast Cancer Cells with Varying Metastatic Potential
    Gangoda, Lahiru
    Liem, Michael
    Ang, Ching-Seng
    Keerthikumar, Shivakumar
    Adda, Christopher G.
    Parker, Belinda S.
    Mathivanan, Suresh
    PROTEOMICS, 2017, 17 (23-24)
  • [40] HYPOTHYROIDISM AS A POTENTIAL BIOMARKER OF EFFICACY OF FAMITINIB, A NOVEL VEGFR2 INHIBITOR IN METASTATIC BREAST CANCER
    Cao, J.
    Zhang, J.
    Wang, Z. H.
    Wang, B. Y.
    Lv, F. F.
    Wang, L. P.
    Hu, X. C.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : E1 - E1